Navigation Links
Agrivida Announces Dan Meagher as Chief Executive Officer
Date:11/18/2013

MEDFORD, Mass., Nov. 18, 2013 /PRNewswire/ -- Agrivida, Inc., a biotechnology company developing technologies for animal nutrition, cellulosic sugars from biomass, and regulated enzymes, announced today the appointment of Dan Meagher as Chief Executive Officer. Mr. Meagher joins Agrivida from Novus International, where he was President of Global Animal Nutrition Solutions and responsible for global sales, marketing, animal R&D, business development, customer service, logistics & distribution and local manufacturing blend facilities.  Prior to Novus, Dan was President of the Egg Products Further Processing Business Unit at MOARK, LLC, a producer and marketer of shell eggs and egg products, COO & Executive Vice President at MBA Poultry LLC, and Vice President at Purina Mills. "I'm extremely excited to be joining Agrivida, whose technology represents a paradigm shift in delivering performance to the animal nutrition industry at the lowest cost possible," stated Mr. Meagher.

Dan takes over at Agrivida as Mark Wong is named to Chairman of Agrivida's Board of Directors.  "We are extremely fortunate to have Dan Meagher joining Agrivida to lead our team into this next phase of development," said Mr. Wong. "Dan's experience in the animal nutrition area will be critical to driving the commercialization of Agrivida's technology in several areas." Mr. Wong assumes the chairman position following five years of service as Agrivida's CEO. During his tenure, Mr. Wong led the company through several successful rounds of financing and established strategic relationships with corn seed and biofuels companies.

Agrivida's new leadership team represents a broadening of the company's expertise, reflecting its growing pipeline of biotechnology products for the animal nutrition, biofuels, and industrial enzyme markets. 

About Agrivida, Inc.

Agrivida is developing and commercializing high-performance products that incorporate novel, regulated proteins precisely engineered for specific applications in a variety of markets, including animal feed and nutrition, bio-based fuels and chemicals, and industrial enzymes. Agrivida is transforming the economics of industrial and agricultural production through our pioneering use of regulated enzymes to develop higher-efficiency, lower-cost biomass feedstocks and intermediate inputs.


'/>"/>
SOURCE Agrivida, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. POET And Agrivida Sign Technology Collaboration Joint Development Agreement
2. QIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired With Lillys Investigational Cancer Compounds
3. Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimers Disease Program
4. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
5. Ceres Announces Webcast of Fiscal Year 2013 Financial Results
6. Anterios, Inc., Announces Results of Consumer Survey Revealing Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatment
7. Cord Blood America Announces 2013 Third Quarter Financial Results
8. IPISC announces IP insurance for the Biotechnology/Pharma Industry
9. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
10. RXi Pharmaceuticals Announces the Start of Their First Phase 2 Study with RXI-109 for Treatment of Hypertrophic Scars in Conjunction with Scar Revision Surgery
11. LayerBio, Inc. Announces Launch; Signs Option for Technology from MIT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... ComplianceOnline, the leading ... has announced its 3rd Annual Medical Device Summit 2017 venue and speaker lineup. The ... House Hotel, in Boston, MA. , The Omni Parker House Hotel, which is located ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... is exhibiting in booth 513 at the Association of Community Cancer Centers (ACCC) ... March 29-31. , CANCERSCAPE unites key stakeholders from leading national organizations to ...
(Date:3/29/2017)... 29, 2017 /PRNewswire/ -  GeneNews Limited (TSX:GEN) ("GeneNews" or ... a new risk stratification test for breast cancer, via its ... Laboratory ("IDL"). BreastSentry incorporates a blood-based biomarker test with a ... for developing breast cancer.   ... BreastSentry measures the fasting plasma levels ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Mass spectrometry is ... utilization of this technology is driven by its potential to perform challenging analyses in ... also some challenges that must be addressed for it to be routinely used for ...
Breaking Biology Technology:
(Date:3/2/2017)... MELBOURNE, Australia , March 2, 2017 ... Therapeutics Ltd (ASX: CYP), has signed an agreement ... researchers from the Monash Biomedicine Discovery Institute and Department ... , to conduct a further preclinical study to support ... the treatment of asthma.  Asthma is ...
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
Breaking Biology News(10 mins):